Medline

Medline ROE

The Return on Equity (ROE) of Medline (MDLN) as of Oct 21, 2026 is 10.79 %. In the previous year, Return on Equity (ROE) was 7.26 % — a change of 48.64% (higher).

ROE

10.79 %

YoY

48.64%

Last updated:

In 2025, Medline's return on equity (ROE) was 10.79 %, a 48.64% increase from the 7.26 % ROE in the previous year.

The Medline ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2023
1.38 USD
Jan 1, 2024
7.26 USD
Jan 1, 2025
10.79 USD
The Medline ROE history
YEARROEYoY
10.79 %+48.64%
7.26 %+426.88%
1.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medline Stock analysis

What does Medline do? Medline Inc generates revenue through its Medline Brand and Supply Chain Solutions segments. The Medline Brand offers approximately 335,000 medical-surgical products organized into Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories, serving hospitals, surgery centers, physician offices, and post-acute facilities. Supply Chain Solutions procures and distributes third-party products from national brands while providing tailored logistics and supply chain optimization services to domestic and international customers. The company's mission-critical products include surgical and procedural kits, gloves, protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Medline Brand products target healthcare facilities requiring daily mission-critical supplies, with Front Line Care focusing on immediate patient care needs, Surgical Solutions supporting operating rooms, and Laboratory and Diagnostics serving clinical testing environments. Supply Chain Solutions serves as a distribution partner for national brands, offering logistics expertise to optimize supply chains for healthcare providers across various care settings. The company's product portfolio supports all points of care, from acute to post-acute facilities, ensuring consistent product availability for daily operations. Customers purchasing Medline Brand products include hospitals, surgery centers, physician offices, and post-acute facilities, while Supply Chain Solutions serves domestic and international clients needing third-party product distribution and supply chain services. The firm's offerings cover the full range of care settings, with Surgical Solutions specifically targeting operating room environments and Laboratory and Diagnostics supporting clinical laboratories. Medline's product range ensures healthcare providers have access to essential supplies without disruption in daily operations. Medline is one of the most popular companies on Eulerpool.

ROE Details

Decoding Medline's Return on Equity (ROE)

Medline's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Medline's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Medline's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Medline’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Medline stock

Return on Equity (ROE) of Medline is 10.79 % in 2025.

Return on Equity (ROE) of Medline changed from 7.26 % to 10.79 %, representing a 48.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Medline since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Medline with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Medline

All Key Metrics — Medline